The Evaluation of Central Corneal Thickness and Intraocular Pressure in Conjunction with Tear IGF-1 Levels in Patients with Acromegaly

Abstract

Purpose

To compare the central corneal thickness (CCT), intraocular pressure (IOP), and tear insulin-like growth factor 1 (IGF-1) levels between patients with acromegaly and a control group and to evaluate the possible effect of tear IGF-1 and duration of the disease on CCT and IOP.

Methods

We included 31 patients with acromegaly (study group) and 40 age- and sex-matched controls in the study. Patients with acromegaly were divided into 2 subgroups based on disease status (active/inactive). All participants underwent complete ophthalmologic evaluation including CCT and IOP values. Basal tear samples were collected from both groups and tear IGF-1 levels were measured. The CCT, IOP, and tear IGF-1 levels were compared between groups and subgroups and the association between tear IGF-I levels and ocular parameters (CCT, IOP) and disease duration were also evaluated.

Results

Central corneal thickness, IOP, and tear IGF-1 levels did not show a significant difference between study and control groups. We also did not find a significant difference in terms of CCT, IOP, or tear IGF-1 levels between subgroups of patients. Correlation analysis did not show an association between the duration of disease and tear IGF-1 levels with CCT or IOP.

Conclusions

There was no significant difference in tear IGF-1 levels between patients with acromegaly and controls. Additionally, there was no correlation between disease duration and tear IGF-1 levels with CCT or IOP levels. This lack of association may suggest that tear IGF-1 levels might not have an effect on CCT or IOP findings in patients with acromegaly.

Keywords

Acromegaly Central corneal thickness Insulin-like growth factor Intraocular pressure Tear collection

Get full access to this article

View all access options for this article.

References

Chanson

Salenave

Acromegaly.

Orphanet J Rare Dis. 2008;25(3):17.

Harvey

Baudet

Sanders

Growth hormone and developmental ocular function: clinical and basic studies.

Pediatr Endocrinol Rev. 2007;5(1):510–515.

Parentin

Pensiero

Central corneal thickness in children with growth hormone deficiency.

Acta Ophthalmol. 2010;88(6):692–694.

Hellström

Svensson

Carlsson

Niklasson

Albertsson-Wikland

Reduced retinal vascularization in children with growth hormone deficiency.

J Clin Endocrinol Metab. 1999;84(2):795–798.

Bourla

Laron

Snir

Lilos

Weinberger

Axer-Siegel

Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome.

Ophthalmology. 2006;113(7): 1197.e1–1197.e5.

Katznelson

Laws

ER Jr

Melmed

et al;

Endocrine Society. Acromegaly: an endocrine society clinical practice guideline.

J Clin Endocrinol Metab. 2014;99(11):3933–3951.

Melmed

Casanueva

Klibanski

et al.

A consensus on the diagnosis and treatment of acromegaly complications. Pituitary. 2013;16(3):294–302.

van Setten

Brismar

Algvere

Elevated intraocular levels of insulin-like growth factor I in a diabetic patient with acromegaly.

Orbit. 2002;21(2):161–167.

Bramsen

Klauber

Bjerre

Central corneal thickness and intraocular tension in patients with acromegaly.

Acta Ophthalmol (Copenh). 1980;58(6):971–974.

10.

Emrah

Elif

Ali

Comparing two acromegalic patients with respect to central corneal thickness, intraocular pressure, and tear insulin-like growth factor levels before and after treatment.

Indian J Ophthalmol. 2015;63(9):731–732.

11.

Scacchi

Cavagnini

Acromegaly.

Pituitary. 2006;9(4):297–303.

12.

Lindholm

Giwercman

Astrup

Bjerre

Skakkebaek

Investigation of the criteria for assessing the outcome of treatment in acromegaly.

Clin Endocrinol (Oxf). 1987;27(5):553–562.

13.

Rocha

Cunha

Carneiro

Boschero

Saad

Velloso

Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface.

Invest Ophthalmol Vis Sci. 2002;43(4):963–967.

14.

Rocha

Cunha

Carneiro

Boschero

Saad

Velloso

Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface.

Adv Exp Med Biol. 2002;506(Pt A):607–610.

15.

Wordinger

Clark

Agarwal

et al.

Cultured human trabecular meshwork cells express functional growth factor receptors.

Invest Ophthalmol Vis Sci. 1998;39(9):1575–1589.

16.

Tamm

Fuchshofer

What increases outflow resistance in primary open-angle glaucoma?

Surv Ophthalmol. 2007;52(Suppl 2):S101–S104.

17.

Altinkaynak

Duru

Ersoy

et al. Topographic and biomechanical evaluation of cornea in patients with acromegaly. Cornea. 2015;34(1):65–70.

18.

Ciresi

Amato

Morreale

Lodato

Galluzzo

Giordano

Cornea in acromegalic patients as a possible target of growth hormone action.

J Endocrinol Invest. 2011;34(2):e30–e35.

19.

Sen

Tutuncu

Elgin

et al.

Comparing acromegalic patients to healthy controls with respect to intraocular pressure, central corneal thickness, and optic disc topography findings.

Indian J Ophthalmol. 2014;62(8):841–845.

20.

Polat

Ugurlu

Ersoy

Oguz

Duru

Cakir

Evaluation of central corneal and central retinal thicknesses and intraocular pressure in acromegaly patients.

Pituitary. 2014;17(4):327–332.

21.

Ozkok

Hatipoglu

Tamcelik

et al.

Corneal biomechanical properties of patients with acromegaly. Br J Ophthalmol. 2014;98(5):651–657.